首页 正文

Beneficial Effect of Upadacitinib in a Refractory Course of Scleritis: A Case Report

{{output}}
Noninfectious scleritis typically takes a chronic course, and systemic corticosteroids or disease-modifying anti-rheumatic drug (DMARD) treatment may be inevitable for a prolonged period. Janus kinase (JAK) inhibitors are a relatively new therapeutic option fo... ...